Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
1141 Cards in this Set
- Front
- Back
rheumatoid
|
arthritis
|
|
chronic
|
autoimmune
|
|
impact
|
of
|
|
sterile
|
proliferative
|
|
is
|
rheumatoid
|
|
women
|
(.36
|
|
what
|
is
|
|
HLA-DR4
|
genotype
|
|
pathogenesis
|
of
|
|
synovium
|
becomes
|
|
pathology
|
of
|
|
disordered
|
cytoarchitecture
|
|
presentation
|
of
|
|
usually
|
insidious
|
|
diagnostic
|
criteria
|
|
morning
|
stiffness
|
|
which
|
joints
|
|
most
|
common
|
|
what
|
hand
|
|
fusiform
|
swelling,
|
|
diagnostic
|
testing
|
|
ESR
|
and
|
|
treatment
|
for
|
|
acetaminophen,
|
NSAIDs,
|
|
management
|
of
|
|
depression
|
can
|
|
prevention
|
of
|
|
evidence
|
exists
|
|
definition
|
of
|
|
idiopathic
|
synovitis
|
|
juvenile
|
idiopathic
|
|
most
|
common
|
|
types
|
(and
|
|
systemic
|
(10%),
|
|
relative
|
incidences
|
|
pauciarticular
|
and
|
|
general
|
presentation
|
|
patient
|
is
|
|
presentation
|
of
|
|
number
|
of
|
|
presentation
|
of
|
|
5
|
or
|
|
presentation
|
of
|
|
4
|
or
|
|
diagnostic
|
testing
|
|
diagnosis
|
based
|
|
treatment
|
of
|
|
pyramid
|
approach:
|
|
management
|
of
|
|
disease
|
can
|
|
prevention
|
of
|
|
psychosocial
|
problems,
|
|
definition
|
of
|
|
asymmetrical
|
sterile
|
|
is
|
reactive
|
|
occurs
|
predominantly
|
|
what
|
is
|
|
strongly
|
associated
|
|
in
|
what
|
|
20-30
|
year
|
|
what
|
types
|
|
those
|
involving
|
|
presentation
|
of
|
|
triad
|
(often
|
|
diagnostic
|
testing
|
|
primarily
|
clinical
|
|
treatment
|
of
|
|
non-pharmaceutical
|
management
|
|
definition
|
of
|
|
arthritis
|
occurring
|
|
what
|
is
|
|
is
|
arthritis
|
|
affects
|
males
|
|
pathogenesis
|
of
|
|
studies
|
suggest
|
|
pathology
|
of
|
|
aseptic
|
inflammation
|
|
presentation
|
of
|
|
symmetric,
|
persistent
|
|
diagnosis
|
of
|
|
rheumatoid
|
factor
|
|
treatment
|
of
|
|
responds
|
to
|
|
definition
|
of
|
|
chronic,
|
progressive
|
|
is
|
ankylosing
|
|
men
|
(2-3:1)
|
|
in
|
what
|
|
usually
|
2nd
|
|
what
|
is
|
|
approximately
|
90%
|
|
what
|
comorbidity
|
|
inflammatory
|
bowel
|
|
possible
|
etiology
|
|
previous
|
enteric
|
|
progression
|
of
|
|
chronic
|
synovitis
|
|
presentation
|
of
|
|
morning
|
stiffness
|
|
diagnosis
|
of
|
|
X-ray
|
of
|
|
what
|
is
|
|
complete
|
fusion
|
|
definition
|
of
|
|
chronic,
|
inflammatory
|
|
prevalence
|
of
|
|
5-10%
|
of
|
|
is
|
psoriatic
|
|
males
|
and
|
|
in
|
what
|
|
between
|
30
|
|
what
|
is
|
|
a
|
genetic
|
|
how
|
does
|
|
histologically
|
similar
|
|
what
|
patient
|
|
HIV
|
patients
|
|
presentation
|
of
|
|
onset:
|
insidious
|
|
diagnostic
|
testing
|
|
seronegative
|
arthritis
|
|
definition
|
of
|
|
complication
|
of
|
|
what
|
percentage
|
|
definition
|
of
|
|
chronic,
|
slowly
|
|
is
|
Sjogren's
|
|
women
|
(9:1)
|
|
in
|
what
|
|
4th
|
and
|
|
Sjogren's
|
syndrome
|
|
second
|
most
|
|
forms
|
of
|
|
primary/Sicca
|
syndrome
|
|
how
|
can
|
|
titer
|
level
|
|
what
|
is
|
|
related
|
to
|
|
suggested
|
origin
|
|
viral
|
(Epstein-Barr
|
|
presentation
|
of
|
|
keratoconjunctivits/xerophthalmia
|
and
|
|
diagnostic
|
testing
|
|
serum
|
autoantibody
|
|
definition
|
of
|
|
multisystem
|
infection
|
|
early
|
presentation
|
|
itchy
|
or
|
|
lymphadenopathy
|
(regional
|
|
late
|
presentation
|
|
scleroderma-like
|
skin
|
|
diagnostic
|
testing
|
|
white
|
blood
|
|
treatment
|
of
|
|
removal
|
of
|
|
management
|
of
|
|
neurologic
|
complications
|
|
prevention
|
of
|
|
protective
|
clothing,
|
|
definition
|
of
|
|
arthritis
|
occurring
|
|
what
|
populations
|
|
immunosuppressed,
|
elderly
|
|
common
|
organisms
|
|
staphylococcus
|
aurus
|
|
rare
|
organisms
|
|
fusobacterium,
|
treponema,
|
|
most
|
common
|
|
knee
|
(55%),
|
|
major
|
routes
|
|
hematogenous
|
spread,
|
|
risk
|
factors
|
|
very
|
young
|
|
presentation
|
of
|
|
acute
|
onset
|
|
diagnostic
|
testing
|
|
arthrocentesis
|
and
|
|
treatment
|
for
|
|
appropriate
|
antibiotic
|
|
management
|
of
|
|
follow-up
|
to
|
|
prevention
|
of
|
|
lifestyle
|
modifications
|
|
definition
|
of
|
|
seeding
|
of
|
|
is
|
gonococcal
|
|
women
|
(4:1
|
|
gonococcal
|
arthritis
|
|
most
|
common
|
|
risk
|
factors
|
|
immunocompromise,
|
debilitating
|
|
prognosis
|
of
|
|
destruction
|
of
|
|
presentation
|
of
|
|
fever,
|
chills
|
|
diagnostic
|
testing
|
|
elevated
|
ESR,
|
|
treatment
|
for
|
|
definition
|
of
|
|
chronic
|
progressive
|
|
how
|
many
|
|
~1-3%
|
of
|
|
risk
|
factors
|
|
alcoholics,
|
HIV-postive
|
|
which
|
joints
|
|
spine
|
>
|
|
special
|
characterisitics
|
|
spine
|
involvement
|
|
mechanism
|
of
|
|
visceral
|
(usually
|
|
presentation
|
of
|
|
insidious
|
onset
|
|
definition
|
of
|
|
arthritis
|
due
|
|
general
|
features
|
|
may
|
be
|
|
potential
|
viral
|
|
parvovirus
|
B19,
|
|
presentation
|
of
|
|
acute
|
to
|
|
types
|
of
|
|
monosodium
|
urate
|
|
what
|
is
|
|
at
|
what
|
|
men
|
at
|
|
etiology
|
of
|
|
hyperuricemia
|
(plasma
|
|
risk
|
factors
|
|
age,
|
genetics,
|
|
presentation
|
of
|
|
acute
|
onset
|
|
diagnostic
|
testing
|
|
diagnosed
|
in
|
|
criteria
|
for
|
|
more
|
than
|
|
treatment
|
of
|
|
prove
|
joint
|
|
management
|
of
|
|
prophylaxis
|
with
|
|
prevention
|
of
|
|
lifestyle
|
changes
|
|
causative
|
molecule
|
|
calcium
|
pyrophosphate
|
|
what
|
type
|
|
usually
|
people
|
|
types
|
of
|
|
idiopathic,
|
hereditary,
|
|
etiology
|
of
|
|
associated
|
with
|
|
etiology
|
of
|
|
associated
|
with
|
|
pathogenesis
|
of
|
|
crystals
|
first
|
|
where
|
does
|
|
knee
|
>
|
|
presentation
|
of
|
|
can
|
be
|
|
diagnostic
|
testing
|
|
arthrocentesis/aspiration,
|
culture
|
|
some
|
synonyms
|
|
basic
|
calcium
|
|
presentation
|
of
|
|
can
|
be
|
|
diagnostic
|
testing
|
|
radiographic
|
studies
|
|
definition
|
of
|
|
disorder
|
of
|
|
hemochromatosis
|
superlative?
|
|
one
|
of
|
|
etiology
|
of
|
|
genetic:
|
hemochromatosis
|
|
pathogenesis
|
of
|
|
iron
|
accumulation
|
|
pathology
|
of
|
|
proliferation
|
of
|
|
presentation
|
of
|
|
arthritis
|
presents
|
|
definitive
|
diagnosis
|
|
hook-like
|
osteophytes
|
|
treatment
|
of
|
|
phlebotomy
|
(does
|
|
definition
|
of
|
|
disease
|
featuring
|
|
types
|
of
|
|
primary
|
(idiopathic),
|
|
osteoarthritis
|
superlatives?
|
|
most
|
common
|
|
distribution
|
of
|
|
under
|
the
|
|
joints
|
commonly
|
|
hip,
|
knees,
|
|
osteophytes
|
presenting
|
|
Heberden
|
nodes
|
|
osteophytes
|
presenting
|
|
Bouchard's
|
nodes
|
|
risk
|
factors
|
|
age,
|
hereditary,
|
|
progression
|
of
|
|
early
|
changes
|
|
presentation
|
of
|
|
deep
|
achy
|
|
diagnostic
|
testing
|
|
radiographic
|
imaging
|
|
treatment
|
for
|
|
symptomatic
|
and
|
|
management
|
of
|
|
viscosupplementation
|
when
|
|
prevention
|
of
|
|
no
|
good
|
|
definition
|
of
|
|
degenerative
|
changes
|
|
difference
|
between
|
|
spinal
|
osteoarthritis
|
|
anterior
|
and
|
|
spondylosis
|
deformans
|
|
narrowing
|
of
|
|
spinal
|
stenosis
|
|
presentation
|
of
|
|
can
|
be
|
|
diagnosis
|
of
|
|
X-ray
|
of
|
|
treatment
|
for
|
|
surgical
|
disk
|
|
definition
|
of
|
|
degeneration
|
of
|
|
presentation
|
of
|
|
pain
|
from
|
|
diagnosis
|
of
|
|
manual
|
tests
|
|
definition
|
of
|
|
severely
|
degenerated
|
|
risk
|
factors
|
|
diabetes
|
mellitus,
|
|
pathognomonic
|
characteristics
|
|
fragments
|
of
|
|
definition
|
of
|
|
typically
|
small
|
|
definition
|
of
|
|
herniated
|
synovial
|
|
etiology
|
of
|
|
cystic
|
or
|
|
treatment
|
of
|
|
painful
|
cysts
|
|
histological
|
distinction
|
|
ganglion
|
cysts
|
|
common
|
example
|
|
Baker
|
cyst:
|
|
definition
|
of
|
|
benign
|
neoplasms
|
|
how
|
can
|
|
cells
|
contain
|
|
at
|
what
|
|
typically
|
in
|
|
types
|
of
|
|
pigmented,
|
giant
|
|
characteristics
|
of
|
|
occurs
|
in
|
|
characteristics
|
of
|
|
occurs
|
in
|
|
definition
|
of
|
|
congenital
|
dysraphisms
|
|
types
|
of
|
|
spina
|
bifida
|
|
presentation
|
of
|
|
spina
|
bifida
|
|
diagnosis
|
of
|
|
neurologic
|
examination,
|
|
prevention
|
of
|
|
folic
|
acid
|
|
definition
|
of
|
|
common
|
congenital
|
|
is
|
metatarsus
|
|
equally
|
distributed
|
|
risk
|
factors
|
|
possibly
|
oligohydramnios
|
|
presentation
|
of
|
|
symptoms
|
are
|
|
diagnosis
|
of
|
|
primarily
|
by
|
|
definition
|
of
|
|
congenital
|
condition
|
|
common
|
causes
|
|
<
|
18
|
|
presentation
|
of
|
|
in-toeing
|
of
|
|
diagnostic
|
testing
|
|
prone
|
thigh-foot
|
|
definition
|
of
|
|
abnormality
|
in
|
|
etiology
|
of
|
|
partial
|
or
|
|
common
|
comorbidity
|
|
other
|
congenital
|
|
presentation
|
of
|
|
tends
|
to
|
|
definition
|
of
|
|
flattening
|
of
|
|
how
|
does
|
|
definition
|
of
|
|
autosomal
|
dominant
|
|
genetic
|
abnormality
|
|
mutation
|
in
|
|
definition
|
of
|
|
can
|
involve
|
|
most
|
common
|
|
fibular
|
hemimelia,
|
|
common
|
types
|
|
hypoplasia/absence
|
of
|
|
common
|
types
|
|
fibular
|
deficiency,
|
|
definition
|
of
|
|
congenital
|
disorder
|
|
common
|
comorbidities
|
|
webbing
|
of
|
|
typical
|
presentation
|
|
scapula
|
can
|
|
definition
|
of
|
|
abnormal
|
structural
|
|
idiopathic
|
scoliosis
|
|
most
|
common
|
|
is
|
idiopathic
|
|
common
|
in
|
|
potential
|
comorbidity
|
|
often
|
accompanied
|
|
types
|
of
|
|
infantile
|
(birth-3
|
|
presentation
|
of
|
|
can
|
be
|
|
what
|
test
|
|
Adams
|
test
|
|
diagnostic
|
testing
|
|
radiographic
|
evaluation
|
|
treatment
|
of
|
|
observation
|
is
|
|
do
|
exercise
|
|
no
|
evidence
|
|
likelihood
|
of
|
|
curvatures
|
of
|
|
prevention
|
and
|
|
untreated
|
scoliosis
|
|
definition
|
of
|
|
idiopathic
|
disorder
|
|
slipped
|
capital
|
|
most
|
common
|
|
risk
|
factors
|
|
obesity,
|
delayed
|
|
developmental
|
progress
|
|
initial
|
event
|
|
presentation
|
of
|
|
progressively
|
worsening
|
|
diagnostic
|
testing
|
|
radographic
|
imaging
|
|
treatment
|
for
|
|
surgical
|
closure
|
|
definition
|
of
|
|
idiopathic
|
congenital
|
|
most
|
common
|
|
amyoplasia
|
(loss
|
|
possible
|
etiology
|
|
death
|
of
|
|
presentation
|
of
|
|
variable
|
distribution
|
|
definition
|
of
|
|
degenerative
|
process
|
|
what
|
region
|
|
thoracic
|
and
|
|
incidence
|
of
|
|
generally
|
believed
|
|
definition
|
of
|
|
infection
|
of
|
|
which
|
bacteria
|
|
Staphylococcus
|
aureus
|
|
most
|
common
|
|
vertebral
|
bodies
|
|
comorbidities
|
that
|
|
being
|
a
|
|
methods
|
of
|
|
hematogenous
|
spread,
|
|
dead
|
pieces
|
|
live
|
bone
|
|
small
|
intraosseous
|
|
Brodie
|
abscesses
|
|
presentation
|
of
|
|
unrelenting
|
pain,
|
|
diagnostic
|
testing
|
|
physical
|
examination,
|
|
treatment
|
of
|
|
antibiotic
|
regimen
|
|
what
|
factors
|
|
delayed
|
diagnosis,
|
|
complications
|
of
|
|
pathologic
|
fracture,
|
|
complications
|
of
|
|
damage
|
to
|
|
prevention
|
of
|
|
physical
|
therapy
|
|
definition
|
of
|
|
osteomyelitis
|
secondary
|
|
risk
|
factors
|
|
alcoholics,
|
HIV-postive
|
|
definition
|
of
|
|
laxity
|
of
|
|
is
|
developmental
|
|
females
|
(9:1)
|
|
common
|
comorbidities
|
|
other
|
forms
|
|
presentation
|
of
|
|
newborns:
|
scanning
|
|
diagnostic
|
testing
|
|
Barlow
|
test,
|
|
treatment
|
of
|
|
varies
|
with
|
|
definition
|
of
|
|
of
|
controversial
|
|
internal
|
femoral
|
|
most
|
common
|
|
is
|
internal
|
|
females
|
(2:1)
|
|
common
|
comorbidity
|
|
generalized
|
ligamentous
|
|
pathology
|
of
|
|
torsion
|
in
|
|
presentation
|
of
|
|
entire
|
lower
|
|
diagnostic
|
testing
|
|
clinical
|
measurement
|
|
definition
|
of
|
|
common
|
foot
|
|
types
|
of
|
|
congenital,
|
teratologic,
|
|
most
|
common
|
|
congenital
|
(75%)
|
|
is
|
talipes
|
|
males
|
(2:1);
|
|
presentation
|
of
|
|
rigidity
|
of
|
|
diagnostic
|
testing
|
|
physical
|
examination;
|
|
definition
|
of
|
|
types
|
of
|
|
physiologic
|
(in
|
|
definition
|
of
|
|
causes
|
of
|
|
physiologic
|
asymmetric
|
|
definition
|
of
|
|
reduction
|
in
|
|
risk
|
factors
|
|
female
|
gender,
|
|
types
|
of
|
|
type
|
I
|
|
presentation
|
of
|
|
may
|
be
|
|
diagnosis
|
of
|
|
densitometry,
|
quantitative
|
|
treatment
|
for
|
|
fracture
|
management,
|
|
management
|
of
|
|
monitoring
|
BMD
|
|
prevention
|
of
|
|
definition
|
of
|
|
impairment
|
of
|
|
presentation
|
of
|
|
usually
|
evident
|
|
distinction
|
between
|
|
both
|
diseases
|
|
most
|
common
|
|
nutritional
|
deficiencies
|
|
physiological
|
impact
|
|
hypocalcemia
|
causing
|
|
presentation
|
of
|
|
generalized
|
muscular
|
|
diagnostic
|
testing
|
|
radiographic
|
imaging,
|
|
treatment
|
of
|
|
multivitamin
|
preparations,
|
|
management
|
of
|
|
severe
|
deformities
|
|
prevention
|
of
|
|
evidence
|
shows
|
|
Paget's
|
disease
|
|
increased
|
remodeling
|
|
possible
|
etiologies
|
|
viral,
|
genetic
|
|
presentation
|
of
|
|
can
|
be
|
|
diagnostic
|
testing
|
|
clinical
|
examination,
|
|
definition
|
of
|
|
form
|
of
|
|
etiology
|
of
|
|
autosomal
|
dominant
|
|
types
|
of
|
|
type
|
I/mild
|
|
presentation
|
of
|
|
fragile
|
bones,
|
|
diagnostic
|
testing
|
|
skin
|
punch
|
|
types
|
of
|
|
osteoma,
|
osteoid
|
|
bone
|
tumor
|
|
benign
|
more
|
|
most
|
common
|
|
osteoid
|
osteomas;
|
|
presentation
|
of
|
|
slow
|
growing
|
|
presentation
|
of
|
|
less
|
than
|
|
presentation
|
of
|
|
usually
|
arise
|
|
diagnostic
|
testing
|
|
radiographic
|
studies
|
|
types
|
of
|
|
osteochondroma
|
(exostosis),
|
|
presentation
|
of
|
|
slow-growing,
|
mushroom-shaped,
|
|
presentation
|
of
|
|
typically
|
an
|
|
chondroblastoma
|
presentation?
|
|
very
|
rare
|
|
diagnostic
|
testing
|
|
radiographic
|
studies:
|
|
definition
|
of
|
|
bone
|
tumors
|
|
types
|
of
|
|
fibrous
|
cortical
|
|
at
|
what
|
|
5-35
|
years
|
|
are
|
benign
|
|
equally
|
common
|
|
characteristics
|
of
|
|
extremely
|
common,
|
|
characteristics
|
of
|
|
fibrous
|
cortical
|
|
characteristics
|
of
|
|
components
|
do
|
|
presentation
|
of
|
|
typically
|
asymptomatic
|
|
diagnostic
|
testing
|
|
radiographic
|
studies
|
|
definition
|
of
|
|
benign
|
but
|
|
at
|
what
|
|
3rd-5th
|
decades
|
|
are
|
giant
|
|
females
|
(2:1)
|
|
which
|
bones
|
|
typically
|
knee
|
|
presentation
|
of
|
|
arthritic-like
|
symptoms
|
|
diagnostic
|
testing
|
|
radiographic
|
studies:
|
|
most
|
common
|
|
osteosarcoma:
|
mesenchymal
|
|
at
|
what
|
|
bimodal
|
age
|
|
are
|
osteosarcomas
|
|
males
|
(1.6:1)
|
|
which
|
bones
|
|
knee
|
(60%),
|
|
etiology
|
of
|
|
mutations
|
in
|
|
presentation
|
of
|
|
painful
|
aggressively
|
|
diagnostic
|
testing
|
|
radiographic
|
studies
|
|
most
|
common
|
|
which
|
is
|
|
osteosarcoma
|
(2:1)
|
|
at
|
what
|
|
>
|
40
|
|
are
|
chondrosarcomas
|
|
males
|
(2:1)
|
|
types
|
of
|
|
primary,
|
secondary
|
|
presentation
|
of
|
|
painful,
|
progressively
|
|
diagnostic
|
testing
|
|
radiographic
|
studies
|
|
definition
|
of
|
|
fibroblastic
|
collagen-producing
|
|
at
|
what
|
|
occur
|
at
|
|
in
|
which
|
|
predilection
|
for
|
|
presentation
|
of
|
|
enlarged
|
painful
|
|
diagnostic
|
testing
|
|
radiographic
|
studies:
|
|
most
|
common
|
|
metastatic
|
bone
|
|
pathways
|
of
|
|
direct
|
extension
|
|
common
|
origins
|
|
"BLT
|
and
|
|
presentation
|
of
|
|
pain
|
(most
|
|
diagnostic
|
testing
|
|
radiographic
|
studies
|
|
second
|
most
|
|
Ewing
|
sarcoma
|
|
where
|
do
|
|
in
|
the
|
|
how
|
do
|
|
small
|
round
|
|
chromosomal
|
abnormality
|
|
presentation
|
of
|
|
painful,
|
enlarging
|
|
diagnostic
|
testing
|
|
radiographic
|
studies
|
|
definition
|
of
|
|
vascular
|
osteonecrosis
|
|
typical
|
age
|
|
usually
|
between
|
|
is
|
Legg-Calve-Perthes
|
|
males
|
(5:1)
|
|
does
|
Legg-Calve-Perthes
|
|
unilaterally
|
(90%)
|
|
presentation
|
of
|
|
hip
|
joint
|
|
potential
|
etiology
|
|
possibly
|
microtrauma
|
|
diagnostic
|
testing
|
|
plain
|
films
|
|
grading
|
of
|
|
grade
|
I
|
|
treatment
|
for
|
|
self-limiting
|
disease;
|
|
management
|
of
|
|
predisposition
|
to
|
|
prevention
|
of
|
|
psychosocial
|
issues
|
|
definition
|
of
|
|
form
|
of
|
|
general
|
characteristics
|
|
occurs
|
more
|
|
possible
|
etiology
|
|
chronic,
|
repetitive
|
|
presentation
|
of
|
|
gradual
|
onset
|
|
diagnostic
|
testing
|
|
radiographic
|
studies
|
|
treatment
|
of
|
|
children
|
younger
|
|
management
|
of
|
|
avascular
|
bone
|
|
definition
|
of
|
|
one
|
of
|
|
Osgood-Schlatter
|
disease
|
|
most
|
common
|
|
is
|
Osgood-Schlatter
|
|
males
|
(3:1)
|
|
presentation
|
of
|
|
severe
|
tenderness
|
|
diagnostic
|
testing
|
|
radiographic
|
studies
|
|
treatment
|
for
|
|
rest,
|
restriction,
|
|
definition
|
of
|
|
vascular
|
infarction
|
|
in
|
what
|
|
hip,
|
knee
|
|
for
|
those
|
|
mutation
|
in
|
|
what
|
factors
|
|
embolization
|
of
|
|
what
|
happens
|
|
compression
|
of
|
|
what
|
is
|
|
creeping
|
substitution
|
|
presentation
|
of
|
|
insidious
|
onset
|
|
diagnostic
|
testing
|
|
radiographic
|
studies:
|
|
treatment
|
of
|
|
precollapse
|
(aim
|
|
management
|
of
|
|
osteonecrosis
|
can
|
|
definition
|
of
|
|
chronic
|
multisystem
|
|
is
|
systemic
|
|
females
|
(9:1)
|
|
principle
|
organs
|
|
skin,
|
joints,
|
|
antibodies
|
detectable
|
|
antinuclear
|
antibodies,
|
|
what
|
genetic
|
|
numerous
|
human
|
|
what
|
type
|
|
Epstein-Barr
|
virus
|
|
common
|
way
|
|
drug
|
induction,
|
|
presentation
|
of
|
|
acute/insidious
|
in
|
|
diagnostic
|
testing
|
|
immunofluoresence
|
testing:
|
|
criteria
|
for
|
|
4
|
or
|
|
treatment
|
for
|
|
non-life-threatening
|
presentations:
|
|
management
|
of
|
|
rare
|
acute
|
|
prevention
|
of
|
|
appropriate
|
vaccines,
|
|
definition
|
of
|
|
acute
|
onset
|
|
erythema
|
nodosum
|
|
most
|
common
|
|
with
|
what
|
|
infections:
|
beta-hemolytic
|
|
presentation
|
of
|
|
poorly
|
defined
|
|
diagnostic
|
testing
|
|
definition
|
of
|
|
rare,
|
multisystem,
|
|
is
|
systemic
|
|
females
|
(3:1)
|
|
what
|
is
|
|
50-60
|
years
|
|
pathogenesis
|
of
|
|
unknown
|
triggering
|
|
types
|
of
|
|
diffuse:
|
wide
|
|
what
|
type
|
|
those
|
for
|
|
presentation
|
of
|
|
insidious
|
origin:
|
|
diagnostic
|
testing
|
|
labs:
|
elevated
|
|
definition
|
of
|
|
syndrome
|
of
|
|
is
|
fibromyalgia
|
|
females
|
(9:1)
|
|
in
|
what
|
|
women
|
over
|
|
potential
|
pathogeneses
|
|
sleep
|
disturbance,
|
|
presentation
|
of
|
|
generalized
|
muscle
|
|
diagnostic
|
testing
|
|
widespread
|
musculoskeletal
|
|
treatment
|
of
|
|
improve
|
quality
|
|
management
|
of
|
|
institute
|
program
|
|
prevention
|
of
|
|
identification
|
and
|
|
definition
|
of
|
|
of
|
idiopathic
|
|
mean
|
age
|
|
70
|
years,
|
|
presentation
|
of
|
|
onset
|
can
|
|
diagnostic
|
testing
|
|
history
|
and
|
|
definition
|
of
|
|
chronic,
|
multisystem
|
|
is
|
sarcoidosis
|
|
African
|
Americans
|
|
is
|
sarcoidosis
|
|
at
|
what
|
|
most
|
often
|
|
etiology
|
of
|
|
disordered
|
immune
|
|
pathogenesis
|
of
|
|
ccumulation
|
of
|
|
most
|
common
|
|
lung
|
(eye
|
|
presentation
|
of
|
|
insidious
|
onset
|
|
diagnostic
|
testing
|
|
history
|
and
|
|
treatment
|
of
|
|
glucocorticoids
|
(first
|
|
definition
|
of
|
|
deposition
|
of
|
|
why
|
is
|
|
because
|
of
|
|
what
|
types
|
|
AL/light
|
chain
|
|
example
|
of
|
|
AL
|
(immunocyte
|
|
example
|
of
|
|
AA
|
(reactive
|
|
examples
|
of
|
|
senile
|
cerebral
|
|
presentation
|
of
|
|
can
|
be
|
|
diagnostic
|
testing
|
|
biopsy
|
and
|
|
definition
|
of
|
|
fibroblastic
|
proliferation,
|
|
in
|
what
|
|
diabetics
|
(type
|
|
at
|
what
|
|
40-60
|
years
|
|
other
|
risk
|
|
hypothyroidism,
|
Dupuytren
|
|
presentation
|
of
|
|
progressive
|
freezing
|
|
diagnostic
|
testing
|
|
physical
|
exam
|
|
treatment
|
for
|
|
NSAIDs,
|
nonnarcotic
|
|
definition
|
of
|
|
sterile
|
inflammation
|
|
common
|
types
|
|
prepatellar
|
bursitis
|
|
common
|
types
|
|
friction
|
bursitis,
|
|
pathogenesis
|
of
|
|
inflammation
|
secondary
|
|
presentation
|
of
|
|
of
|
the
|
|
diagnostic
|
testing
|
|
physical
|
exam
|
|
treatment
|
of
|
|
NSAIDs,
|
ice,
|
|
definition
|
of
|
|
painful
|
tissue
|
|
types
|
of
|
|
lateral
|
(tennis
|
|
pathogenesis
|
of
|
|
small
|
tears
|
|
at
|
what
|
|
35-50
|
years
|
|
presentation
|
of
|
|
gradual
|
onset
|
|
diagnostic
|
testing
|
|
physical
|
exam
|
|
diagnostic
|
testing
|
|
similar
|
presentation
|
|
treatment
|
for
|
|
modifying
|
the
|
|
definition
|
of
|
|
recently
|
coined
|
|
pathogenesis
|
of
|
|
tendinitis
|
(inflammation)
|
|
how
|
is
|
|
by
|
region
|
|
presentation
|
of
|
|
pain
|
on
|
|
diagnostic
|
testing
|
|
physical
|
exam
|
|
treatment
|
for
|
|
NSAIDs
|
(early
|
|
definition
|
of
|
|
inflammation
|
of
|
|
in
|
what
|
|
women
|
who
|
|
presentation
|
of
|
|
pain
|
and
|
|
diagnostic
|
testing
|
|
physical
|
exam
|
|
treatment
|
for
|
|
rest
|
with
|
|
definition
|
of
|
|
systemic
|
vasculitis
|
|
what
|
other
|
|
polymyalgia
|
rheumatica
|
|
giant
|
cell
|
|
most
|
common
|
|
at
|
what
|
|
after
|
age
|
|
is
|
giant
|
|
in
|
what
|
|
Nordic
|
population
|
|
etiology
|
of
|
|
autoimmune:
|
associated
|
|
pathology
|
of
|
|
involvement
|
extends
|
|
presentation
|
of
|
|
vague,
|
non-specific
|
|
diagnostic
|
testing
|
|
ESR,
|
CBC,
|
|
treatment
|
for
|
|
glucocorticoid
|
therapy,
|
|
management
|
of
|
|
visual
|
impairment
|
|
prevention
|
of
|
|
major
|
goal
|
|
definition
|
of
|
|
systemic
|
necrotizing
|
|
at
|
what
|
|
around
|
57
|
|
is
|
microscopic
|
|
with
|
what
|
|
p-ANCA
|
(protoplasmic-staining
|
|
etiology
|
of
|
|
immune
|
reaction
|
|
presentation
|
of
|
|
initially
|
fever,
|
|
diagnostic
|
testing
|
|
elevated
|
ESR,
|
|
definition
|
of
|
|
systemic
|
necrotizing
|
|
where
|
in
|
|
at
|
bifurcations
|
|
pathogenesis
|
of
|
|
acutely:
|
polymorphonuclear
|
|
what
|
organ
|
|
how
|
does
|
|
as
|
arteritis
|
|
what
|
immunologic
|
|
strong
|
association
|
|
presentation
|
of
|
|
non-specific
|
signs
|
|
diagnostic
|
testing
|
|
no
|
specific
|
|
definition
|
of
|
|
involves
|
a
|
|
etiology
|
of
|
|
most
|
likely
|
|
typical
|
Takayasu
|
|
woman
|
under
|
|
pathology
|
of
|
|
panarteritis
|
with
|
|
presentation
|
of
|
|
generalized
|
signs
|
|
diagnostic
|
testing
|
|
arteriography
|
is
|
|
definition
|
of
|
|
necrotizing
|
vasculitis
|
|
at
|
what
|
|
~40
|
years
|
|
pathology
|
of
|
|
triad
|
of
|
|
other
|
organs
|
|
eyes,
|
skin,
|
|
etiology
|
and
|
|
autoimmune
|
triggered
|
|
presentation
|
of
|
|
non-specific
|
signs
|
|
diagnostic
|
testing
|
|
elevated
|
ESR,
|
|
definition
|
of
|
|
common
|
lesion
|
|
presentation
|
of
|
|
small
|
firm
|
|
definition
|
of
|
|
benign
|
proliferation
|
|
types
|
of
|
|
superficial,
|
deep
|
|
examples
|
of
|
|
palmar
|
(DupuytrenÕs
|
|
is
|
palmar
|
|
males
|
(5:1)
|
|
presentation
|
of
|
|
slowly
|
progressing
|
|
definition
|
of
|
|
rare
|
but
|
|
where
|
in
|
|
retroperitoneum,
|
thigh,
|
|
at
|
what
|
|
30-55
|
years
|
|
malignancy
|
of
|
|
aggressive
|
tumors
|
|
diagnostic
|
testing
|
|
definition
|
of
|
|
benign
|
tumors
|
|
lipoma
|
superlative?
|
|
most
|
common
|
|
pathological
|
impact
|
|
mass
|
effect
|
|
diagnostic
|
testing
|
|
definition
|
of
|
|
sarcoma
|
of
|
|
liposarcoma
|
superlative?
|
|
one
|
of
|
|
at
|
what
|
|
40-60
|
years
|
|
where
|
in
|
|
deep
|
soft
|
|
presentation
|
of
|
|
no
|
characteristic
|
|
diagnostic
|
testing
|
|
definition
|
of
|
|
aggressive
|
malignant
|
|
at
|
what
|
|
7th
|
decade
|
|
types
|
of
|
|
storiform-pleomorphic,
|
myxoid,
|
|
where
|
in
|
|
musculature
|
of
|
|
presentation
|
of
|
|
painless
|
mass
|
|
diagnostic
|
testing
|
|
definition
|
of
|
|
fibrotic
|
proliferation
|
|
typical
|
etiology
|
|
typically
|
in
|
|
presentation
|
of
|
|
initially
|
an
|
|
diagnostic
|
testing
|
|
radiographic
|
studies:
|
|
definition
|
of
|
|
chronic
|
inflammatory
|
|
what
|
population
|
|
male
|
patients
|
|
presentation
|
of
|
|
heliotrophic
|
rash
|
|
diagnostic
|
testing
|
|
lab
|
studies:
|
|
definition
|
of
|
|
subacute
|
inflammatory
|
|
etiology
|
of
|
|
autoimmune
|
process:
|
|
presentation
|
of
|
|
presents
|
without
|
|
diagnostic
|
testing
|
|
lab
|
studies:
|
|
definition
|
of
|
|
benign
|
tumors
|
|
leiomyoma
|
superlative?
|
|
most
|
common
|
|
at
|
what
|
|
adolescence
|
or
|
|
presentation
|
of
|
|
dependent
|
on
|
|
definition
|
of
|
|
malignant
|
tumors
|
|
are
|
leiomyosarcomas
|
|
where
|
in
|
|
most
|
develop
|
|
presentation
|
of
|
|
painless
|
firm
|
|
definition
|
of
|
|
rare,
|
but
|
|
rhabdomyosarcoma
|
superlative?
|
|
most
|
common
|
|
at
|
what
|
|
before
|
20
|
|
where
|
in
|
|
most
|
often
|
|
etiology
|
of
|
|
PAX3-FKHR
|
gene
|
|
types
|
of
|
|
embryonal
|
(most
|
|
malignancy
|
of
|
|
aggressive
|
tumors
|
|
presentation
|
of
|
|
mass
|
expanding
|